A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm-Reference-Cited by-同舟云学术

A C-terminal mutant of CCAAT-enhancer-binding protein α (C/EBPα-Cm) downregulates Csf1r, a potent accelerator in the progression of acute myeloid leukemia with C/EBPα-Cm

Published:2015-04 Issue:4 Volume:43 Page:300-308.e1
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Togami Katsuhiro,Kitaura Jiro,Uchida Tomoyuki,Inoue Daichi,Nishimura Koutarou,Kawabata Kimihito C.,Nagase Reina,Horikawa Sayuri,Izawa Kumi,Fukuyama Tomofusa,Nakahara Fumio,Oki Toshihiko,Harada Yuka,Harada Hironori,Aburatani Hiroyuki,Kitamura Toshio

Funder

Ministry of Education, Science, Technology, Sports and Culture, Japan

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference29 articles.

1. Enhancement of hematopoietic stem cell repopulating capacity and self-renewal in the absence of the transcription factor C/EBP alpha;Zhang;Immunity,2004

2. Transcription factors, normal myeloid development, and leukemia;Tenen;Blood,1997

3. Identification of two polypeptide segments of CCAAT/enhancer-binding protein required for transcriptional activation of the serum albumin gene;Friedman;Genes Dev,1990

4. The DNA binding domain of the rat liver nuclear protein C/EBP is bipartite;Landschulz;Science,1989

5. CCAAT/enhancer binding protein-alpha amino acid motifs with dual TBP and TFIIB binding ability co-operate to activate transcription in both yeast and mammalian cells;Nerlov;EMBO J,1995

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor suppressor CEBPA interacts with and inhibits DNMT3A activity;Science Advances;2022-01-28

2. Transcriptional mechanisms that control expression of the macrophage colony-stimulating factor receptor locus;Clinical Science;2017-07-31

3. High expression of ABCG2 induced by EZH2 disruption has pivotal roles in MDS pathogenesis;Leukemia;2017-07-19

4. Metaplastic Breast Cancer: Molecular Typing and Identification of Potential Targeted Therapies at a Single Institution;Clinical Breast Cancer;2017-02

5. The multifaceted functions of C/EBPα in normal and malignant haematopoiesis;Leukemia;2015-11-25